$NVIDIA (NVDA.US)$ Finally got 5$ cash dividend! now i can die peacfully 🤣

Recently, $NVIDIA (NVDA.US)$ has suffered pullbacks, with its market capitalization dropping to third place due to a 7% decrease in stock price between June 21 and June 25 closing.
Whether you are a current $NVIDIA (NVDA.US)$ investor or still on the sidelines, the upcoming shareholder meeting on June 26th at 9:00 AM PT is a crucial event that can provide valuable insights for informed investment decisions in s...

$NVIDIA (NVDA.US)$ has announced a 10-for-1 stock split, which is set to take place on June 10, 2024. This means each current share will be divided into 10, reducing the price per share to one-tenth.
Key Date
June 6: Own shares by June 6, 4 PM EDT to be eligible for the stock split.
June 7:  Last day to trade shares at the pre-split price and receive 9 additional shares on June 7.
June 10: Split-adjusted trading begins on June 10.
Why It matters
A...

$SPDR S&P Biotech ETF (XBI.US)$
$Merck & Co (MRK.US)$ x $Immunovant (IMVT.US)$
$Eli Lilly and Co (LLY.US)$ x $Cytokinetics (CYTK.US)$ (and soon)
$Regeneron Pharmaceuticals (REGN.US)$ x $Apellis Pharmaceuticals (APLS.US)$ (panache & brash)
$Gilead Sciences (GILD.US)$ x % $Madrigal Pharmaceuticals (MDGL.US)$ (liver king)
$Bristol-Myers Squibb (BMY.US)$ x $Iovance Biotherapeutics (IOVA.US)$ (cell Tx boost needed)
$Eli Lilly and Co (LLY.US)$ x $Merus (MRUS.US)$ (partner n...

The FDA PDUFA Calendar is a chronological calendar of PDUFA target dates as well as Advisory meetings (ADCOMM). PDUFA target dates are dates by which the FDA aims to deliver their decision regarding an NDA or BLA filing. These decisions can however come before the PDUFA target date.
$Vanda Pharmaceuticals (VNDA.US)$ $Legend Biotech (LEGN.US)$ $Supernus Pharmaceuticals (SUPN.US)$ $ImmunityBio (IBRX.US)$ $Aquestive Therapeutics (AQST.US)$ $X4 Pharmaceuticals (XFOR.US)$ $Liquidia (LQDA.US)$ $Neurocrine Biosciences (NBIX.US)$ $Moderna (MRNA.US)$ $Day One Biopharmaceuticals (DAWN.US)$
...

🎯 Ph 3 readouts in Q2 2024...
$Intra-Cellular Therapies (ITCI.US)$  Phase 3
$CG Oncology (CGON.US)$  Phase 3
$Hutchmed (China) (HCM.US)$  Phase 3
$Viracta Therapeutics (VIRX.US)$  Phase 3
$GlycoMimetics (GLYC.US)$  Phase 3
$Annexon (ANNX.US)$  Phase 3
$Lipocine (LPCN.US)$  Phase 3
$FibroGen (FGEN.US)$  Phase 3
$UroGen Pharma Ltd (URGN.US)$  Phase 3
$Lyra Therapeutics (LYRA.US)$  Phase 3
$Citius Pharmaceuticals (CTXR.US)$  Phase 3
$Marinus Pharmaceuticals (MRNS.US)$  Phase 3
$BioCardia (BCDA.US)$  Phase 3...

$Femto Technologies (BCAN.US)$ Always REMEMBER:
1. Buy LOW Sell HIGH
2. Don’t Chase Highs. Avoid FOMO. The stock market will always be there. You may miss out on a runner. There are many stocks EVERYTIME to trade.
3. Don’t hope for the moon. Be realistic. Setting profit targets- I do 10,15,20,25,30% targets. You may think its small but rolling over profits will have a compounding effect.
4. Avoid bagholding.
5. Make sure you set a Stop-Loss. If you don’t, make sure you are glued to your atock window ...

$Eyenovia (EYEN.US)$ HC Wainwright & Co. analyst Matthew Caufield reiterates Eyenovia with a Buy and maintains $12 price target.

$SeaStar Medical (ICU.US)$ will see how the trial goes

$Fortress Biotech (FBIO.US)$ $Mustang Bio (MBIO.US)$ City of Hope-developed Chimeric Antigen Receptor (CAR) T Cell Therapy Shows Clinical Activity in Patients With Aggressive Brain Tumors in a Phase 1 Trial
4 MINUTES AGO, 5:00 AM EST
VIA BUSINESSWIRE
• Half of the enrolled patients had stable disease for at least two months, two showed partial response and two experienced complete response
• Nature Medicine paper highlights delivery of CAR T cell therapy directly to the brain, a technique Ci...